UNSPSC 51283508: Cloxacillin sodium anhydrous

This classification denotes a penicillin antibiotic C19H17ClN3O5S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MWQ645MKMF, chemically known as cloxacillin sodium, anhydrous, but more generally known as cloxacillin sodium anhydrous, which bears US NIH Compound Identifier 23675320. Most nations, for tariff and trade purposes, schedule cloxacillin sodium anhydrous under HS 29411090 and SITC 54131. As of Q4 2014, CLOXACILLIN SODIUM ANHYDROUS remains US FDA's Preferred Term for this commodity.

Cloxacillin sodium anhydrous bears US NLM identifiers UMLS ID C2699387 and NCI Concept Code C76222. SMILES: CC1C(C(NO1)C2CCCCC2CL)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].[NA+].

UNSPSC 51283508 Cloxacillin sodium anhydrous, a Commodity code, shows minimal relevant recent activity in state and local procurement. The code nominally identifies a specific antibiotic pharmaceutical product, yet the recent opportunities posted under this code do not involve cloxacillin sodium anhydrous at all. The Illinois Department of Public Health awarded a completed piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and Seminole County, Florida issued an IFB for Naloxone and Safe Drug Deactivation Systems—neither of which corresponds to the code's stated commodity. This mismatch suggests either inconsistent code assignment by the issuing bodies or that cloxacillin sodium anhydrous procurement does not currently move through state and local channels tagged with this code.

No open solicitations for cloxacillin sodium anhydrous or materially related pharmaceutical products appear in the recent opportunities block. The Illinois award (Bid Number 26-482DPH-PREPD-B-53392, completed August 28, 2026, total value $2,999,999.11 over 36 months) demonstrates that state health departments do procure antibiotics through cooperative purchasing vehicles and IFB processes, but the specific products purchased diverge from this code. If your firm supplies cloxacillin sodium anhydrous to state or local health systems, monitoring this code's future activity may reveal category-alignment changes; for now, the code shows no active opportunities matching its nominal scope.